We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sale of New DNA Sequencers Keep Pace with Growing Demand

By LabMedica International staff writers
Posted on 17 Sep 2012
A new, 3rd edition of the “DNA Sequencing Equipment and Services Markets” report by Kalorama Information (New York City, NY, USA) provides an in-depth examination of factors currently considered most influential in the DNA sequencing market, including an analysis of sales trends and an overview of currently available products. More...


Sales of DNA sequencers increased in the last year with the introduction of new systems and a growing demand for sequencing, according to the healthcare market research publisher Kalorama Information. Introductions of the Ion Torrent PGM, PacBio RS, and MiSeq grew the market nearly 5% to USD 560 million in 2011. More new technologies are expected that may further change the market and introduce price changes. "This was getting to be a stable market, but that changed in the last two years," said Justin Saeks, Kalorama analyst and author of the report; "Now it's more volatile and complicated; we think customers will acquire new systems, but pricing and feature preferences will get interesting." In addition to analyzing and forecasting DNA sequencer sales, the report also looks at sequencer consumables and services sales.

According to the report, DNA sequencing has seen very high growth in recent years as labs have decided to use next-generation sequencing, though large segments of end-users still use CE Sanger systems. The science of sequencing is constantly evolving, particularly as more clinical applications are sought and competition with other technologies is resolved. Just one of many trends: large structural variations have shown to be highly important for genetic variation (more so than SNPs) so read lengths then become a key factor in purchases. "Longer-term, questions still remain for broad areas such as disease prevention and diagnostics which could turn into home runs or strikeouts," said Mr. Saeks.

The report also examines the competitive positions of players and says competition will be intense as systems are constantly improved and new products appear. It suggests customer criteria and priorities may change so specific features might be make-or-break depending on the applications that are discovered; as specific applications place emphasis on one benefit or another, the market segments can then narrow down their usage to certain products.

Related Links:

Kalorama Information
DNA Sequencing Equipment and Services Markets, 3rd Edition



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Portable Electronic Pipette
Mini 96
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.